EXTENSION AGREEMENTExtension Agreement • March 23rd, 2010 • Callisto Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Agreement made as of this th day of March, 2010 between Callisto Pharmaceuticals, Inc., a Delaware corporation (the “Company”) having a principal place of business at 420 Lexington Avenue, Suite 1609, New York, New York 10170, and the holders of the Company’s outstanding 6% Secured Promissory Notes due April 15, 2010 (the “Notes”) that has executed this Agreement on Schedule I hereto. Each such holder is referred to herein as the “Lender” and., collectively the “Lenders.”
